Cargando…

The feasibility of gene therapy in the treatment of head and neck cancer

Standard approach to the treatment of head and neck cancer include surgery, chemotherapy, and radiation. More recently, dramatic increases in our knowledge of the molecular and genetic basis of cancer combined with advances in technology have resulted in novel molecular therapies for this disease. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Vattemi, Emanuela, Claudio, Pier Paolo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2640478/
https://www.ncbi.nlm.nih.gov/pubmed/19284676
http://dx.doi.org/10.1186/1758-3284-1-3
_version_ 1782164581581324288
author Vattemi, Emanuela
Claudio, Pier Paolo
author_facet Vattemi, Emanuela
Claudio, Pier Paolo
author_sort Vattemi, Emanuela
collection PubMed
description Standard approach to the treatment of head and neck cancer include surgery, chemotherapy, and radiation. More recently, dramatic increases in our knowledge of the molecular and genetic basis of cancer combined with advances in technology have resulted in novel molecular therapies for this disease. In particular, gene therapy, which involves the transfer of genetic material to cells to produce a therapeutic effect, has become a promising approach. Clinical trials concerning gene therapy strategies in head and neck cancer as well as combination of these strategies with chemotherapy and radiation therapy will be discussed.
format Text
id pubmed-2640478
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26404782009-02-12 The feasibility of gene therapy in the treatment of head and neck cancer Vattemi, Emanuela Claudio, Pier Paolo Head Neck Oncol Review Standard approach to the treatment of head and neck cancer include surgery, chemotherapy, and radiation. More recently, dramatic increases in our knowledge of the molecular and genetic basis of cancer combined with advances in technology have resulted in novel molecular therapies for this disease. In particular, gene therapy, which involves the transfer of genetic material to cells to produce a therapeutic effect, has become a promising approach. Clinical trials concerning gene therapy strategies in head and neck cancer as well as combination of these strategies with chemotherapy and radiation therapy will be discussed. BioMed Central 2009-01-12 /pmc/articles/PMC2640478/ /pubmed/19284676 http://dx.doi.org/10.1186/1758-3284-1-3 Text en Copyright © 2009 Vattemi and Claudio; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Vattemi, Emanuela
Claudio, Pier Paolo
The feasibility of gene therapy in the treatment of head and neck cancer
title The feasibility of gene therapy in the treatment of head and neck cancer
title_full The feasibility of gene therapy in the treatment of head and neck cancer
title_fullStr The feasibility of gene therapy in the treatment of head and neck cancer
title_full_unstemmed The feasibility of gene therapy in the treatment of head and neck cancer
title_short The feasibility of gene therapy in the treatment of head and neck cancer
title_sort feasibility of gene therapy in the treatment of head and neck cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2640478/
https://www.ncbi.nlm.nih.gov/pubmed/19284676
http://dx.doi.org/10.1186/1758-3284-1-3
work_keys_str_mv AT vattemiemanuela thefeasibilityofgenetherapyinthetreatmentofheadandneckcancer
AT claudiopierpaolo thefeasibilityofgenetherapyinthetreatmentofheadandneckcancer
AT vattemiemanuela feasibilityofgenetherapyinthetreatmentofheadandneckcancer
AT claudiopierpaolo feasibilityofgenetherapyinthetreatmentofheadandneckcancer